Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese: The results of a 15-Year Chinese Multi-Provincial Cohort Study (CMCS)

Atherosclerosis

Volumn 211, Issue 1, 2010, Pages 327-332

  Ren, Jie ^a   Grundy, Scott M ^b   Liu, Jing ^a   Wang, Wei ^a   Wang, Miao ^a   Sun, Jiayi ^a   Liu, Jun ^a   Li, Yan ^a   Wu, Zhaosu ^a   Zhao, Dong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Coronary heart disease; Follow up studies; Very low density lipoprotein cholesterol

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETES MELLITUS; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHINA; COHORT ANALYSIS; CORONARY DISEASE; MIDDLE AGED; RISK FACTOR;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; COHORT STUDIES; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 77954315039     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.02.020     Document Type: Article

References (25)

1. National Cholesterol Education Program (NCEP), Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
2. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi 2007, 35:390-419.
3. McPherson R., Frohlich J., Fodor G., Genest J. Canadian Cardiovascular Society. Canadian Cardiovascular Society position statement-Recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 2006, 22:913-927.
4. Tonkin A., Barter P., Best J., et al. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. Position statement on lipid management-2005. Heart Lung Circ 2005, 14:275-291.
5. Wood D., De Backer G., Faergeman O., et al. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 1998, 140:199-270.
6. Lu W., Resnick H.E., Jablonski K.A., et al. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. Diabetes Care 2003, 26:16-23.
7. Farwell W.R., Sesso H.D., Buring J.E., Gaziano J.M. Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction. Am J Cardiol 2005, 96:1129-1134.
8. Ciardullo A.V., Azzolini L., Bevini M., et al. Non-HDL cholesterol predicts coronary heart disease in primary prevention: findings from an Italian 40-69 year-old cohort in general practice. Monaldi Arch Chest Dis 2004, 62:69-72.
9. Bittner V., Hardison R., Kelsey S.F., et al. Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 2002, 106:2537-2542.
10. Liu J., Sempos C.T., Donahue R.P., et al. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol 2006, 98:1363-1368.
11. Koba S., Hirano T., Sakaue T., et al. An increased number of very-low-density lipoprotein particles is strongly associated with coronary heart disease in Japanese men, independently of intermediate-density lipoprotein or low-density lipoprotein. Coron Artery Dis 2002, 13:255-262.
12. Zhao W.H., Zhang J., You Y., et al. Epidemiologic characteristics of dyslipidemia in people aged 18 years and over in China. Zhonghua Yu Fang Yi Xue Za Zhi 2005, 39:306-310.
13. Zhao W.H., Zhang J., Zhai Y., et al. Blood lipid profile and prevalence of dyslipidemia in Chinese adults. Biomed Environ Sci 2007, 20:329-335.
14. Sarwar N., Danesh J., Eiriksdottir G., et al. Triglycerides and the risk of coronary heart disease: 10 158 incident cases among 262525 participants in 29 western prospective studies. Circulation 2007, 115:450-458.
15. Wu Z.S., Yao C.H., Zhao D., et al. A prospective cohort study on cardiovascular disease incidence in 11 provinces of China. I. Associations between risk factor level and cardiovascular disease incidence. Chin J Cardiol 1999, 27:5-8.
16. World Health Organization Multination monitoring of treads and determinants in cardiovascular disease (MONICA project) and manual of operation 1993, Cardiovascular Disease Unit, Geneva.
17. Friedewald W., Levy R., Fredrickson D. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
18. Phillips N., Water D., Havel R. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993, 88:2762-2770.
19. Kugiyama K., Doi H., Takazoe K., et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation 1999, 99:2858-2860.
20. Masuoka H., Kamei S., Wagayama H., et al. Association of remnant-like particle cholesterol with coronary artery disease in patients with normal total cholesterol levels. Am Heart J 2000, 139:305-310.
21. Fukushima H., Sugiyama S., Honda O., et al. Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus. J Am Coll Cardiol 2004, 43:2219-2224.
22. Cui Y., Blumenthal R.S., Flaws J.A., et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001, 161:1413-1419.
23. Liu J., Sempos C., Donahue R., et al. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care 2005, 28:1916-1921.
24. Brunzell J.D., Davidson M., Furberg C.D., et al. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care 2008, 31:811-822.
25. Grundy S.M. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy. Circulation 2002, 106:2526-2529.